## SCHW: Charles Schwab Corporation (The - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.65 indicates fundamental undervaluation. Quality metrics strong (ROE 17%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($93.21)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. SVB Wealth LLC Invests $2.72 Million in The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251209T124959 | Bullish | Relevance: 99%
-  SVB Wealth LLC has initiated a new position in The Charles Schwab Corporation, acquiring 29,837 shares valued at approximately $2.72 million. This investment is part of broader institutional activity, with institutions now owning about 84.4% of SCHW. The Charles Schwab Corporation reported strong Q2 earnings, beating analyst estimates with $1.31 EPS and $6.38 billion in revenue, and maintains a "Moderate Buy" consensus rating from analysts.

**2. State Street Corp Boosts Stock Position in The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251209T131358 | Bullish | Relevance: 98%
-  State Street Corp increased its stake in The Charles Schwab Corporation by 0.7% in Q2, acquiring an additional 531,329 shares to hold a total of 72,464,619 shares, valued at approximately $6.61 billion. Charles Schwab reported strong quarterly earnings, beating analyst expectations with $1.31 EPS and $6.38 billion in revenue, reflecting a 26.6% year-over-year increase. Analysts maintain a "Moderate Buy" consensus rating with an average target price of $107.11, while the company also declared a quarterly dividend of $0.27 per share.

**3. UBS assumes coverage on Charles Schwab stock with Buy rating**
- Source: Investing.com | 20251211T063613 | Bullish | Relevance: 98%
-  UBS has initiated coverage on Charles Schwab Corp. (NYSE:SCHW) with a Buy rating and a price target of $119.00, noting the company's strong position in the mass-affluent brokerage and RIA custody sectors. The investment bank anticipates significant EPS growth for Schwab in 2025 and an expansion of its operating margin by 2028, driven by scale, innovation, and strategic M&A. This positive outlook is further supported by recent corporate developments, including senior note issuance, an acquisition, and an improved S&P Global Ratings outlook.

**4. Natixis Sells 193,429 Shares of The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251210T115455 | Neutral | Relevance: 98%
- Natixis significantly reduced its stake in The Charles Schwab Corporation by 67.6% in the second quarter, selling 193,429 shares and now holding 92,703 shares valued at approximately $8.46 million. In related news, company insiders Jonathan S. Beatty and Paul V. Woolway also sold shares. Analysts maintain a "Moderate Buy" consensus rating for SCHW with an average price target of $107.11, and the company recently surpassed quarterly EPS estimates.

**5. First Trust Advisors LP Has $51.26 Million Stake in The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251209T093312 | Somewhat-Bullish | Relevance: 97%
-  First Trust Advisors LP significantly increased its stake in The Charles Schwab Corporation (NYSE:SCHW) by 260.9% in the second quarter, valuing its holdings at $51.26 million. This move is part of a broader trend of institutional investors and hedge funds acquiring a substantial portion of Charles Schwab's stock, with such entities now owning 84.38% of the company. Wall Street analysts maintain a "Moderate Buy" consensus rating for SCHW, with an average price target of $107.11, following several positive re-ratings and price target increases.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | B of A Securiti | $91 | $88 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | B of A Securiti | main | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($1.54M) |
| Sells | 14 ($11.74M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.5% (+0.3%)
- Blackrock Inc.: 7.4% (+3.2%)
- JPMORGAN CHASE & CO: 6.8% (+71.6%)
- Dodge & Cox Inc.: 4.7% (-1.6%)
- State Street Corpora: 4.1% (+0.9%)

### Key Risks

1. Heavy insider selling: $12M sold (14 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +3.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.65 indicates undervaluation relative to growth. Quality metrics strong (margin 36%). Insider selling cluster ($11.7M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $176.2B |
| Beta | 0.96 |
| 52W Range | $65.88 - $99.59 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.65 |
| Forward P/E | 17.3 |
| Current P/E | 20.2 |
| YoY Growth | 16.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -1.6% to 2.0% (+3.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.0pp (needs >4.0% for momentum thesis). MRS_5 at 2.1% confirms short-term momentum alignment. AM_20 at 4.2% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.52), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.02% (CS: 59) | Neutral |
| RSI_14 | 63.9 | Neutral |
| MACD Histogram | 0.52 | Bullish |
| vs SMA20 | 1.042x | Above |
| vs SMA50 | 1.034x | Above |
| vs SMA200 | 1.089x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $97.05
- **Stop Loss:** $93.21 (4.0% risk)
- **Target:** $104.73 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 359
- **Position Value:** $34,840.95
- **Portfolio %:** 34.84%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-21 (Est: $1.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.25 | $1.31 | +5.2% |
| 2025Q2 | $1.10 | $1.14 | +3.8% |
| 2025Q1 | $1.01 | $1.04 | +3.2% |
| 2024Q4 | $0.91 | $1.01 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*